| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Copy Number Variations | 42 | 2025 | 949 | 2.630 |
Why?
|
| Computational Biology | 12 | 2020 | 811 | 2.030 |
Why?
|
| Genetic Diseases, Inborn | 15 | 2024 | 443 | 1.920 |
Why?
|
| Comparative Genomic Hybridization | 27 | 2017 | 572 | 1.780 |
Why?
|
| Software | 6 | 2020 | 683 | 1.750 |
Why?
|
| Chromosome Aberrations | 23 | 2019 | 616 | 1.530 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 43 | 2025 | 1016 | 1.460 |
Why?
|
| Disease | 4 | 2020 | 129 | 1.300 |
Why?
|
| Chromosome Disorders | 17 | 2019 | 311 | 1.230 |
Why?
|
| Genome, Human | 24 | 2025 | 1273 | 1.220 |
Why?
|
| High-Throughput Nucleotide Sequencing | 8 | 2020 | 882 | 1.180 |
Why?
|
| Models, Statistical | 3 | 2020 | 471 | 1.170 |
Why?
|
| Mosaicism | 10 | 2020 | 240 | 1.160 |
Why?
|
| Blood Platelets | 9 | 2019 | 327 | 1.110 |
Why?
|
| Gene Expression Regulation | 25 | 2023 | 2521 | 1.090 |
Why?
|
| Models, Theoretical | 3 | 2020 | 358 | 1.090 |
Why?
|
| Phenotype | 28 | 2022 | 4256 | 1.010 |
Why?
|
| Sequence Analysis, DNA | 12 | 2020 | 1758 | 0.940 |
Why?
|
| Polymorphism, Single Nucleotide | 18 | 2019 | 2634 | 0.840 |
Why?
|
| Gene Dosage | 15 | 2013 | 439 | 0.830 |
Why?
|
| Genome-Wide Association Study | 12 | 2019 | 1684 | 0.820 |
Why?
|
| Microbiota | 5 | 2020 | 391 | 0.790 |
Why?
|
| Codon, Nonsense | 3 | 2021 | 131 | 0.780 |
Why?
|
| Nonsense Mediated mRNA Decay | 2 | 2021 | 29 | 0.780 |
Why?
|
| Genomic Instability | 9 | 2018 | 228 | 0.700 |
Why?
|
| Respiratory Syncytial Virus, Human | 4 | 2017 | 204 | 0.680 |
Why?
|
| Exons | 10 | 2025 | 796 | 0.670 |
Why?
|
| Humans | 167 | 2025 | 124601 | 0.660 |
Why?
|
| Genetic Techniques | 2 | 2018 | 106 | 0.650 |
Why?
|
| Exome | 13 | 2022 | 1034 | 0.650 |
Why?
|
| Mutation | 23 | 2024 | 5825 | 0.640 |
Why?
|
| Microarray Analysis | 6 | 2019 | 229 | 0.640 |
Why?
|
| Algorithms | 6 | 2024 | 1619 | 0.620 |
Why?
|
| Gene Expression Profiling | 22 | 2016 | 1702 | 0.620 |
Why?
|
| Gametogenesis | 3 | 2017 | 24 | 0.610 |
Why?
|
| Genetic Testing | 6 | 2024 | 1001 | 0.590 |
Why?
|
| Bayes Theorem | 3 | 2020 | 284 | 0.590 |
Why?
|
| Chromosome Deletion | 14 | 2023 | 647 | 0.580 |
Why?
|
| MicroRNAs | 10 | 2015 | 837 | 0.570 |
Why?
|
| Genes, Reporter | 2 | 2018 | 381 | 0.570 |
Why?
|
| Models, Genetic | 11 | 2019 | 759 | 0.570 |
Why?
|
| Genomics | 12 | 2022 | 1502 | 0.560 |
Why?
|
| Respiratory Syncytial Virus Infections | 4 | 2017 | 342 | 0.550 |
Why?
|
| Genetic Variation | 10 | 2020 | 1497 | 0.550 |
Why?
|
| Nerve Tissue Proteins | 12 | 2016 | 1112 | 0.540 |
Why?
|
| Sequence Deletion | 12 | 2018 | 526 | 0.530 |
Why?
|
| Quantitative Trait Loci | 3 | 2019 | 288 | 0.530 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2019 | 3153 | 0.530 |
Why?
|
| Alleles | 10 | 2019 | 1615 | 0.530 |
Why?
|
| In Situ Hybridization, Fluorescence | 26 | 2016 | 763 | 0.520 |
Why?
|
| RNA Splice Sites | 1 | 2016 | 89 | 0.510 |
Why?
|
| Inheritance Patterns | 3 | 2017 | 127 | 0.500 |
Why?
|
| Gene Duplication | 10 | 2018 | 362 | 0.500 |
Why?
|
| Biomarkers, Tumor | 2 | 2021 | 1485 | 0.500 |
Why?
|
| Germ-Line Mutation | 2 | 2014 | 332 | 0.490 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 143 | 0.480 |
Why?
|
| Mitochondrial Proteins | 2 | 2016 | 229 | 0.480 |
Why?
|
| Breast Neoplasms | 10 | 2019 | 2498 | 0.480 |
Why?
|
| Protein Interaction Mapping | 2 | 2014 | 85 | 0.470 |
Why?
|
| RNA, Messenger | 14 | 2016 | 2816 | 0.460 |
Why?
|
| Nucleic Acid Hybridization | 9 | 2010 | 395 | 0.440 |
Why?
|
| Abnormalities, Multiple | 10 | 2023 | 959 | 0.420 |
Why?
|
| Spinocerebellar Ataxias | 6 | 2013 | 252 | 0.420 |
Why?
|
| Nuclear Proteins | 13 | 2024 | 1265 | 0.420 |
Why?
|
| Transcription, Genetic | 16 | 2017 | 1697 | 0.420 |
Why?
|
| Female | 90 | 2024 | 66492 | 0.420 |
Why?
|
| Trophoblasts | 3 | 2019 | 113 | 0.420 |
Why?
|
| Metagenomics | 1 | 2014 | 102 | 0.420 |
Why?
|
| Receptors, Thrombin | 4 | 2018 | 12 | 0.420 |
Why?
|
| Epilepsy | 4 | 2013 | 871 | 0.410 |
Why?
|
| Bronchiolitis | 3 | 2019 | 120 | 0.410 |
Why?
|
| Gene Deletion | 6 | 2018 | 791 | 0.400 |
Why?
|
| Animals | 70 | 2024 | 34085 | 0.390 |
Why?
|
| Viral Proteins | 1 | 2014 | 347 | 0.390 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 6 | 2015 | 309 | 0.390 |
Why?
|
| Homologous Recombination | 7 | 2022 | 91 | 0.370 |
Why?
|
| Mice | 48 | 2023 | 17639 | 0.370 |
Why?
|
| Rare Diseases | 2 | 2024 | 191 | 0.370 |
Why?
|
| Single-Cell Analysis | 5 | 2019 | 275 | 0.360 |
Why?
|
| Genotype | 14 | 2018 | 2556 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 17 | 5 | 2019 | 369 | 0.360 |
Why?
|
| Male | 79 | 2024 | 61199 | 0.360 |
Why?
|
| Base Sequence | 16 | 2022 | 3090 | 0.350 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2013 | 538 | 0.350 |
Why?
|
| Gene Regulatory Networks | 5 | 2016 | 351 | 0.340 |
Why?
|
| Platelet Activation | 3 | 2015 | 71 | 0.320 |
Why?
|
| Autistic Disorder | 6 | 2013 | 343 | 0.320 |
Why?
|
| Cell Line, Tumor | 15 | 2019 | 3339 | 0.310 |
Why?
|
| DNA Replication | 5 | 2019 | 352 | 0.310 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 717 | 0.300 |
Why?
|
| Alu Elements | 3 | 2018 | 65 | 0.300 |
Why?
|
| Repressor Proteins | 6 | 2021 | 816 | 0.300 |
Why?
|
| Dictyostelium | 6 | 2004 | 114 | 0.300 |
Why?
|
| Signal Transduction | 11 | 2019 | 4504 | 0.290 |
Why?
|
| Circadian Rhythm | 5 | 2007 | 272 | 0.290 |
Why?
|
| Genetic Markers | 4 | 2019 | 604 | 0.290 |
Why?
|
| Neoplasms | 2 | 2021 | 2772 | 0.280 |
Why?
|
| Molecular Sequence Data | 18 | 2015 | 3878 | 0.280 |
Why?
|
| Polymerase Chain Reaction | 9 | 2015 | 1586 | 0.270 |
Why?
|
| Nasopharynx | 2 | 2018 | 79 | 0.270 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2012 | 82 | 0.270 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2022 | 401 | 0.270 |
Why?
|
| Genotyping Techniques | 3 | 2016 | 103 | 0.270 |
Why?
|
| Nasal Cavity | 2 | 2018 | 50 | 0.260 |
Why?
|
| Gene Expression | 7 | 2016 | 1562 | 0.260 |
Why?
|
| Intellectual Disability | 8 | 2017 | 1056 | 0.260 |
Why?
|
| Platelet Aggregation | 3 | 2015 | 120 | 0.260 |
Why?
|
| Transcriptome | 5 | 2016 | 952 | 0.260 |
Why?
|
| Ataxia | 3 | 2014 | 169 | 0.250 |
Why?
|
| DNA Methylation | 5 | 2019 | 1003 | 0.250 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2017 | 214 | 0.250 |
Why?
|
| Phospholipid Transfer Proteins | 2 | 2017 | 15 | 0.250 |
Why?
|
| Membrane Proteins | 7 | 2017 | 1533 | 0.250 |
Why?
|
| Gene Rearrangement | 5 | 2019 | 320 | 0.250 |
Why?
|
| Genes, Viral | 2 | 2017 | 185 | 0.250 |
Why?
|
| Homozygote | 3 | 2019 | 548 | 0.240 |
Why?
|
| INDEL Mutation | 3 | 2020 | 87 | 0.240 |
Why?
|
| Pregnancy | 12 | 2020 | 7182 | 0.240 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 2 | 2018 | 19 | 0.240 |
Why?
|
| Cell Differentiation | 11 | 2019 | 1891 | 0.240 |
Why?
|
| DNA Repair | 4 | 2019 | 585 | 0.240 |
Why?
|
| Trisomy | 4 | 2011 | 102 | 0.230 |
Why?
|
| Receptor, ErbB-2 | 2 | 2019 | 514 | 0.230 |
Why?
|
| Germ Cells | 3 | 2014 | 194 | 0.230 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 280 | 0.230 |
Why?
|
| Bronchiolitis, Viral | 2 | 2016 | 30 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2017 | 86 | 0.230 |
Why?
|
| Hypothalamus | 3 | 2013 | 221 | 0.230 |
Why?
|
| Translocation, Genetic | 4 | 2012 | 357 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2019 | 100 | 0.230 |
Why?
|
| Interferons | 2 | 2017 | 124 | 0.220 |
Why?
|
| DNA Helicases | 4 | 2024 | 231 | 0.220 |
Why?
|
| Anophthalmos | 1 | 2024 | 24 | 0.220 |
Why?
|
| Gene Amplification | 2 | 2014 | 228 | 0.220 |
Why?
|
| Coloboma | 1 | 2024 | 45 | 0.220 |
Why?
|
| Microphthalmos | 1 | 2024 | 60 | 0.220 |
Why?
|
| DNA | 7 | 2016 | 1597 | 0.220 |
Why?
|
| Genes, myc | 2 | 2015 | 100 | 0.220 |
Why?
|
| Prevotella | 2 | 2020 | 8 | 0.220 |
Why?
|
| Longitudinal Studies | 4 | 2020 | 1322 | 0.210 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2018 | 235 | 0.210 |
Why?
|
| Genome, Viral | 1 | 2024 | 168 | 0.210 |
Why?
|
| Developmental Disabilities | 6 | 2016 | 712 | 0.210 |
Why?
|
| Neoplasm Metastasis | 5 | 2017 | 665 | 0.210 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2022 | 16 | 0.200 |
Why?
|
| Anorectal Malformations | 1 | 2022 | 14 | 0.200 |
Why?
|
| Scimitar Syndrome | 1 | 2023 | 52 | 0.200 |
Why?
|
| Moraxella | 2 | 2019 | 14 | 0.200 |
Why?
|
| Virus Replication | 2 | 2024 | 610 | 0.200 |
Why?
|
| Child, Preschool | 23 | 2024 | 14009 | 0.200 |
Why?
|
| DNA-Binding Proteins | 5 | 2015 | 2045 | 0.200 |
Why?
|
| Streptococcus | 2 | 2019 | 61 | 0.200 |
Why?
|
| Esophageal Atresia | 1 | 2022 | 51 | 0.200 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2022 | 48 | 0.200 |
Why?
|
| Mixed Function Oxygenases | 2 | 2012 | 30 | 0.190 |
Why?
|
| Adult | 24 | 2024 | 29440 | 0.190 |
Why?
|
| Infant | 19 | 2024 | 12468 | 0.190 |
Why?
|
| Smith-Magenis Syndrome | 3 | 2019 | 105 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 17 | 2016 | 4409 | 0.190 |
Why?
|
| Immunity, Humoral | 2 | 2013 | 70 | 0.190 |
Why?
|
| RNA, Viral | 1 | 2024 | 540 | 0.190 |
Why?
|
| Prenatal Diagnosis | 5 | 2019 | 597 | 0.190 |
Why?
|
| Cell Line | 9 | 2019 | 2750 | 0.180 |
Why?
|
| Cell Proliferation | 6 | 2017 | 2287 | 0.180 |
Why?
|
| MEF2 Transcription Factors | 2 | 2019 | 42 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 1 | 4 | 2011 | 140 | 0.180 |
Why?
|
| Telomere | 4 | 2008 | 213 | 0.180 |
Why?
|
| Karyotyping | 9 | 2014 | 328 | 0.180 |
Why?
|
| Chromosome Breakpoints | 6 | 2019 | 80 | 0.180 |
Why?
|
| Chromosomes, Human, X | 3 | 2012 | 157 | 0.180 |
Why?
|
| Myocytes, Cardiac | 4 | 2023 | 603 | 0.180 |
Why?
|
| Mutation Rate | 3 | 2024 | 66 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2011 | 72 | 0.180 |
Why?
|
| Young Adult | 13 | 2019 | 9014 | 0.180 |
Why?
|
| Staphylococcus | 2 | 2018 | 70 | 0.180 |
Why?
|
| Thrombosis | 3 | 2015 | 519 | 0.180 |
Why?
|
| Transcription Factors | 7 | 2024 | 2584 | 0.180 |
Why?
|
| Rett Syndrome | 3 | 2015 | 291 | 0.170 |
Why?
|
| Hospitals | 1 | 2023 | 388 | 0.170 |
Why?
|
| Chromosome Mapping | 9 | 2023 | 1079 | 0.170 |
Why?
|
| Hematopoiesis | 3 | 2014 | 215 | 0.170 |
Why?
|
| Segmental Duplications, Genomic | 4 | 2015 | 81 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2018 | 882 | 0.170 |
Why?
|
| Cytogenetic Analysis | 5 | 2012 | 80 | 0.170 |
Why?
|
| Endothelial Cells | 1 | 2023 | 521 | 0.170 |
Why?
|
| Pyridines | 2 | 2018 | 229 | 0.170 |
Why?
|
| Mevalonic Acid | 1 | 2019 | 19 | 0.160 |
Why?
|
| CD36 Antigens | 1 | 2019 | 37 | 0.160 |
Why?
|
| Nasal Mucosa | 1 | 2019 | 65 | 0.160 |
Why?
|
| Respiratory Sounds | 1 | 2019 | 68 | 0.160 |
Why?
|
| Child | 24 | 2024 | 24374 | 0.160 |
Why?
|
| Coronary Vessels | 1 | 2023 | 537 | 0.160 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2018 | 369 | 0.160 |
Why?
|
| Thrombopoiesis | 1 | 2019 | 11 | 0.160 |
Why?
|
| Cohort Studies | 11 | 2018 | 4795 | 0.160 |
Why?
|
| Rhinovirus | 2 | 2016 | 59 | 0.160 |
Why?
|
| Trinucleotide Repeat Expansion | 3 | 2015 | 125 | 0.160 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2019 | 31 | 0.160 |
Why?
|
| Osteochondrodysplasias | 2 | 2012 | 66 | 0.150 |
Why?
|
| Megakaryocytes | 1 | 2019 | 42 | 0.150 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 25 | 0.150 |
Why?
|
| Lactones | 1 | 2018 | 38 | 0.150 |
Why?
|
| Disease Models, Animal | 13 | 2017 | 4352 | 0.150 |
Why?
|
| Genomic Imprinting | 1 | 2019 | 123 | 0.150 |
Why?
|
| Pre-Eclampsia | 1 | 2020 | 221 | 0.150 |
Why?
|
| Myocardium | 3 | 2007 | 997 | 0.150 |
Why?
|
| Mammary Glands, Animal | 2 | 2015 | 481 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2011 | 160 | 0.150 |
Why?
|
| Cell Cycle Proteins | 3 | 2018 | 642 | 0.150 |
Why?
|
| Adolescent | 19 | 2024 | 19278 | 0.150 |
Why?
|
| WAGR Syndrome | 1 | 2017 | 7 | 0.150 |
Why?
|
| Influenza, Human | 2 | 2015 | 657 | 0.150 |
Why?
|
| Biological Assay | 1 | 2018 | 103 | 0.140 |
Why?
|
| Evolution, Molecular | 4 | 2024 | 669 | 0.140 |
Why?
|
| Genetic Association Studies | 4 | 2015 | 778 | 0.140 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 104 | 0.140 |
Why?
|
| Databases, Genetic | 4 | 2018 | 473 | 0.140 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2017 | 33 | 0.140 |
Why?
|
| Aneuploidy | 3 | 2014 | 152 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2015 | 616 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2016 | 1284 | 0.140 |
Why?
|
| Hemizygote | 1 | 2017 | 13 | 0.140 |
Why?
|
| Influenza Vaccines | 2 | 2013 | 478 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 2 | 2017 | 354 | 0.140 |
Why?
|
| Heart Defects, Congenital | 2 | 2023 | 1813 | 0.140 |
Why?
|
| Phosphofructokinase-1 | 1 | 2016 | 5 | 0.140 |
Why?
|
| Bone Marrow | 1 | 2019 | 324 | 0.140 |
Why?
|
| Paracrine Communication | 1 | 2017 | 69 | 0.140 |
Why?
|
| Chromosome Breakage | 6 | 2011 | 167 | 0.140 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 1350 | 0.140 |
Why?
|
| Maternal Serum Screening Tests | 1 | 2016 | 3 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 210 | 0.140 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 193 | 0.130 |
Why?
|
| Hormones | 1 | 2017 | 186 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2014 | 118 | 0.130 |
Why?
|
| Ataxins | 6 | 2013 | 114 | 0.130 |
Why?
|
| Influenza B virus | 2 | 2015 | 87 | 0.130 |
Why?
|
| CELF1 Protein | 1 | 2016 | 48 | 0.130 |
Why?
|
| Loss of Heterozygosity | 2 | 2015 | 125 | 0.130 |
Why?
|
| Pedigree | 6 | 2019 | 1605 | 0.130 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2016 | 66 | 0.130 |
Why?
|
| Heterotaxy Syndrome | 1 | 2016 | 61 | 0.130 |
Why?
|
| Myocardial Contraction | 2 | 2007 | 265 | 0.130 |
Why?
|
| Recombination, Genetic | 3 | 2019 | 448 | 0.130 |
Why?
|
| Transgenes | 2 | 2014 | 334 | 0.130 |
Why?
|
| Pharynx | 1 | 2016 | 64 | 0.130 |
Why?
|
| Antigens, Viral | 2 | 2017 | 439 | 0.130 |
Why?
|
| Prognosis | 3 | 2021 | 4625 | 0.130 |
Why?
|
| Ataxin-1 | 6 | 2013 | 162 | 0.130 |
Why?
|
| Carrier Proteins | 3 | 2018 | 1022 | 0.130 |
Why?
|
| Picornaviridae Infections | 1 | 2016 | 48 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2015 | 5 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 469 | 0.130 |
Why?
|
| Epithelial Cells | 3 | 2016 | 909 | 0.120 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2015 | 16 | 0.120 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 263 | 0.120 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2015 | 78 | 0.120 |
Why?
|
| Receptors, IgG | 1 | 2015 | 59 | 0.120 |
Why?
|
| Placenta | 1 | 2019 | 506 | 0.120 |
Why?
|
| Mutagenesis, Insertional | 3 | 2015 | 146 | 0.120 |
Why?
|
| Endonucleases | 1 | 2015 | 54 | 0.120 |
Why?
|
| Data Mining | 1 | 2015 | 53 | 0.120 |
Why?
|
| Spliceosomes | 1 | 2015 | 53 | 0.120 |
Why?
|
| Drosophila | 3 | 2015 | 782 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 759 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 22 | 3 | 2012 | 103 | 0.120 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2015 | 32 | 0.120 |
Why?
|
| DNA, Mitochondrial | 2 | 2009 | 211 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2016 | 1387 | 0.120 |
Why?
|
| Retrospective Studies | 8 | 2023 | 16317 | 0.120 |
Why?
|
| Infant, Newborn | 12 | 2017 | 8191 | 0.120 |
Why?
|
| Biomarkers | 3 | 2020 | 3063 | 0.120 |
Why?
|
| Primates | 1 | 2015 | 77 | 0.120 |
Why?
|
| Chorionic Villi Sampling | 2 | 2012 | 45 | 0.120 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2017 | 501 | 0.120 |
Why?
|
| Chromosome Duplication | 4 | 2019 | 147 | 0.120 |
Why?
|
| Endogenous Retroviruses | 1 | 2014 | 17 | 0.120 |
Why?
|
| Cell Lineage | 2 | 2014 | 338 | 0.120 |
Why?
|
| Uniparental Disomy | 1 | 2015 | 49 | 0.120 |
Why?
|
| Williams Syndrome | 2 | 2012 | 40 | 0.110 |
Why?
|
| Blood Cells | 1 | 2014 | 49 | 0.110 |
Why?
|
| Amniocentesis | 2 | 2012 | 77 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2015 | 197 | 0.110 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2014 | 12 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2017 | 310 | 0.110 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2014 | 10 | 0.110 |
Why?
|
| Wilms Tumor | 1 | 2015 | 113 | 0.110 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2015 | 131 | 0.110 |
Why?
|
| Phosphorylation | 5 | 2019 | 1615 | 0.110 |
Why?
|
| Spasms, Infantile | 1 | 2016 | 171 | 0.110 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2015 | 71 | 0.110 |
Why?
|
| Contig Mapping | 1 | 2014 | 55 | 0.110 |
Why?
|
| Proteome | 2 | 2014 | 243 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2012 | 150 | 0.110 |
Why?
|
| Recurrence | 2 | 2014 | 1420 | 0.110 |
Why?
|
| Fathers | 1 | 2014 | 68 | 0.110 |
Why?
|
| Likelihood Functions | 1 | 2014 | 113 | 0.110 |
Why?
|
| Reproducibility of Results | 8 | 2017 | 2876 | 0.110 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 1947 | 0.110 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 481 | 0.110 |
Why?
|
| Rotavirus Infections | 1 | 2017 | 355 | 0.110 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2013 | 32 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 1108 | 0.110 |
Why?
|
| Aging, Premature | 1 | 2013 | 30 | 0.110 |
Why?
|
| In Situ Hybridization | 3 | 2010 | 470 | 0.110 |
Why?
|
| Tetraspanins | 1 | 2013 | 30 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 37 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2015 | 278 | 0.110 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2013 | 27 | 0.100 |
Why?
|
| Barrett Esophagus | 2 | 2009 | 340 | 0.100 |
Why?
|
| Fragile X Syndrome | 1 | 2014 | 150 | 0.100 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2013 | 42 | 0.100 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2008 | 93 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2014 | 132 | 0.100 |
Why?
|
| DNA, Viral | 1 | 2014 | 480 | 0.100 |
Why?
|
| Fetus | 1 | 2016 | 586 | 0.100 |
Why?
|
| Tremor | 1 | 2014 | 129 | 0.100 |
Why?
|
| DNA Primers | 1 | 2014 | 657 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 292 | 0.100 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2013 | 115 | 0.100 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 59 | 0.100 |
Why?
|
| Cell Communication | 2 | 2003 | 165 | 0.100 |
Why?
|
| Chromosomes, Human | 3 | 2008 | 130 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 120 | 0.100 |
Why?
|
| Down-Regulation | 5 | 2017 | 699 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2010 | 94 | 0.100 |
Why?
|
| Genes, Recessive | 1 | 2013 | 185 | 0.100 |
Why?
|
| Bone and Bones | 2 | 2019 | 266 | 0.100 |
Why?
|
| ras Proteins | 1 | 2013 | 137 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2015 | 271 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 206 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 3 | 2024 | 372 | 0.100 |
Why?
|
| Platelet Adhesiveness | 1 | 2012 | 40 | 0.100 |
Why?
|
| Genes, X-Linked | 1 | 2012 | 59 | 0.100 |
Why?
|
| Heart | 2 | 2007 | 708 | 0.100 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 5 | 0.100 |
Why?
|
| Cerebellum | 3 | 2011 | 413 | 0.100 |
Why?
|
| Receptors, Opioid, mu | 1 | 2012 | 30 | 0.100 |
Why?
|
| Language Development Disorders | 1 | 2013 | 174 | 0.100 |
Why?
|
| Carnitine | 1 | 2012 | 74 | 0.100 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2011 | 23 | 0.100 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2012 | 58 | 0.100 |
Why?
|
| Preimplantation Diagnosis | 1 | 2012 | 23 | 0.100 |
Why?
|
| Phylogeny | 1 | 2014 | 695 | 0.090 |
Why?
|
| Nephrotic Syndrome | 1 | 2012 | 48 | 0.090 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 172 | 0.090 |
Why?
|
| Arteriosclerosis | 1 | 2012 | 144 | 0.090 |
Why?
|
| Texas | 3 | 2017 | 3583 | 0.090 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2013 | 178 | 0.090 |
Why?
|
| Sex Characteristics | 2 | 2014 | 314 | 0.090 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 71 | 0.090 |
Why?
|
| Syndrome | 5 | 2014 | 1119 | 0.090 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 673 | 0.090 |
Why?
|
| Mothers | 1 | 2014 | 351 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 433 | 0.090 |
Why?
|
| Cartilage | 2 | 2008 | 49 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2008 | 997 | 0.090 |
Why?
|
| User-Computer Interface | 1 | 2012 | 154 | 0.090 |
Why?
|
| Frameshift Mutation | 2 | 2022 | 180 | 0.090 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2019 | 969 | 0.090 |
Why?
|
| Sexual Development | 1 | 2010 | 21 | 0.090 |
Why?
|
| Chromosome Banding | 4 | 2014 | 140 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2011 | 57 | 0.090 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2012 | 116 | 0.090 |
Why?
|
| Mice, Transgenic | 5 | 2015 | 2393 | 0.090 |
Why?
|
| Gene Frequency | 3 | 2018 | 722 | 0.090 |
Why?
|
| Family Health | 1 | 2011 | 258 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1882 | 0.090 |
Why?
|
| Cell Survival | 3 | 2018 | 806 | 0.090 |
Why?
|
| Social Behavior | 1 | 2012 | 209 | 0.090 |
Why?
|
| Autism Spectrum Disorder | 1 | 2015 | 384 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 273 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1660 | 0.080 |
Why?
|
| Interleukin-13 | 1 | 2010 | 97 | 0.080 |
Why?
|
| Medical Records | 1 | 2010 | 189 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2011 | 153 | 0.080 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2012 | 205 | 0.080 |
Why?
|
| Calcium Channels | 1 | 2010 | 160 | 0.080 |
Why?
|
| Purkinje Cells | 2 | 2014 | 159 | 0.080 |
Why?
|
| Sensitivity and Specificity | 7 | 2009 | 2050 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2018 | 707 | 0.080 |
Why?
|
| Middle Aged | 9 | 2018 | 26714 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2012 | 177 | 0.080 |
Why?
|
| Pathology, Molecular | 2 | 2022 | 58 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2010 | 142 | 0.080 |
Why?
|
| Inhibin-beta Subunits | 1 | 2009 | 18 | 0.080 |
Why?
|
| Charcot-Marie-Tooth Disease | 2 | 2012 | 199 | 0.080 |
Why?
|
| Sex Chromosomes | 1 | 2009 | 34 | 0.080 |
Why?
|
| Microdissection | 1 | 2009 | 12 | 0.080 |
Why?
|
| Behavior, Animal | 1 | 2012 | 493 | 0.080 |
Why?
|
| Macular Degeneration | 1 | 2010 | 114 | 0.080 |
Why?
|
| Cells, Cultured | 6 | 2013 | 3040 | 0.080 |
Why?
|
| Brain | 4 | 2016 | 2983 | 0.080 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 64 | 0.080 |
Why?
|
| Schizophrenia | 1 | 2011 | 300 | 0.080 |
Why?
|
| De Lange Syndrome | 2 | 2019 | 44 | 0.080 |
Why?
|
| Syndactyly | 1 | 2008 | 24 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 716 | 0.080 |
Why?
|
| RNA Editing | 1 | 2008 | 34 | 0.080 |
Why?
|
| Mice, Mutant Strains | 4 | 2011 | 383 | 0.080 |
Why?
|
| Protozoan Proteins | 3 | 2004 | 111 | 0.070 |
Why?
|
| Lasers | 1 | 2009 | 114 | 0.070 |
Why?
|
| K562 Cells | 2 | 2019 | 95 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2008 | 8 | 0.070 |
Why?
|
| Extremities | 1 | 2008 | 82 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 465 | 0.070 |
Why?
|
| Somatomedins | 1 | 2008 | 36 | 0.070 |
Why?
|
| Trastuzumab | 2 | 2019 | 134 | 0.070 |
Why?
|
| Vaccination | 1 | 2013 | 954 | 0.070 |
Why?
|
| Mice, Knockout | 5 | 2016 | 3732 | 0.070 |
Why?
|
| Drosophila melanogaster | 1 | 2013 | 771 | 0.070 |
Why?
|
| Hypothalamic Diseases | 1 | 2008 | 37 | 0.070 |
Why?
|
| Mitochondrial Diseases | 1 | 2009 | 133 | 0.070 |
Why?
|
| Oleic Acid | 1 | 2007 | 15 | 0.070 |
Why?
|
| Biological Clocks | 1 | 2007 | 28 | 0.070 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2007 | 36 | 0.070 |
Why?
|
| Penetrance | 3 | 2012 | 102 | 0.070 |
Why?
|
| Lithium Carbonate | 1 | 2007 | 19 | 0.070 |
Why?
|
| Platelet Count | 2 | 2019 | 136 | 0.070 |
Why?
|
| DiGeorge Syndrome | 1 | 2008 | 79 | 0.070 |
Why?
|
| Curcumin | 1 | 2007 | 41 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 163 | 0.070 |
Why?
|
| Schwann Cells | 1 | 2007 | 57 | 0.070 |
Why?
|
| Antimanic Agents | 1 | 2007 | 30 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2010 | 284 | 0.070 |
Why?
|
| Myelin Proteins | 1 | 2007 | 75 | 0.070 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 660 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2008 | 183 | 0.070 |
Why?
|
| Angelman Syndrome | 1 | 2007 | 67 | 0.070 |
Why?
|
| Genes, tat | 1 | 2006 | 10 | 0.070 |
Why?
|
| Heterochromatin | 1 | 2006 | 49 | 0.070 |
Why?
|
| Tissue Array Analysis | 2 | 2018 | 137 | 0.070 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2006 | 22 | 0.070 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2006 | 27 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2018 | 547 | 0.070 |
Why?
|
| Cell Separation | 3 | 2018 | 227 | 0.070 |
Why?
|
| Body Composition | 1 | 2009 | 522 | 0.060 |
Why?
|
| Retroviridae | 1 | 2006 | 198 | 0.060 |
Why?
|
| Genetic Counseling | 3 | 2017 | 220 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2017 | 2705 | 0.060 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2007 | 147 | 0.060 |
Why?
|
| Cyclins | 1 | 2006 | 101 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2006 | 114 | 0.060 |
Why?
|
| Hair Diseases | 1 | 2005 | 14 | 0.060 |
Why?
|
| Case-Control Studies | 4 | 2015 | 3281 | 0.060 |
Why?
|
| Congenital Abnormalities | 1 | 2008 | 255 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2006 | 136 | 0.060 |
Why?
|
| Heterografts | 2 | 2017 | 171 | 0.060 |
Why?
|
| Protein Biosynthesis | 3 | 2016 | 664 | 0.060 |
Why?
|
| Rats, Wistar | 4 | 2007 | 359 | 0.060 |
Why?
|
| Genes, Immediate-Early | 1 | 2005 | 5 | 0.060 |
Why?
|
| Cluster Analysis | 3 | 2013 | 398 | 0.060 |
Why?
|
| Anxiety | 1 | 2012 | 941 | 0.060 |
Why?
|
| Periodicity | 1 | 2005 | 55 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 307 | 0.060 |
Why?
|
| RNA, Untranslated | 1 | 2005 | 113 | 0.060 |
Why?
|
| Cranial Sutures | 1 | 2005 | 32 | 0.060 |
Why?
|
| In Vitro Techniques | 3 | 2014 | 969 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2016 | 6135 | 0.060 |
Why?
|
| Neurons | 1 | 2015 | 1957 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2017 | 285 | 0.060 |
Why?
|
| Cell Cycle | 4 | 2011 | 610 | 0.060 |
Why?
|
| Jejunum | 1 | 2005 | 129 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2018 | 457 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2015 | 1895 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2008 | 375 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 355 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2017 | 568 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2009 | 775 | 0.060 |
Why?
|
| Monocytes | 1 | 2006 | 352 | 0.060 |
Why?
|
| Hypoglycemia | 2 | 2017 | 191 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2006 | 346 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 504 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2014 | 369 | 0.050 |
Why?
|
| Monosomy | 1 | 2003 | 24 | 0.050 |
Why?
|
| SOXF Transcription Factors | 1 | 2023 | 18 | 0.050 |
Why?
|
| Aged | 4 | 2018 | 19703 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 249 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6533 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2010 | 820 | 0.050 |
Why?
|
| Endothelium | 1 | 2023 | 70 | 0.050 |
Why?
|
| Meiosis | 1 | 2003 | 113 | 0.050 |
Why?
|
| Trans-Activators | 3 | 2016 | 800 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2024 | 314 | 0.050 |
Why?
|
| Risk Factors | 2 | 2014 | 10270 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2003 | 324 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2006 | 940 | 0.050 |
Why?
|
| Asthma | 1 | 2010 | 749 | 0.050 |
Why?
|
| Stochastic Processes | 1 | 2002 | 34 | 0.050 |
Why?
|
| Animals, Genetically Modified | 2 | 2014 | 314 | 0.050 |
Why?
|
| Proteins | 2 | 2011 | 1036 | 0.050 |
Why?
|
| Risk | 2 | 2015 | 755 | 0.050 |
Why?
|
| HIV-1 | 1 | 2006 | 465 | 0.050 |
Why?
|
| Protein Interaction Maps | 2 | 2013 | 78 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 177 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2005 | 381 | 0.050 |
Why?
|
| Macrophages | 1 | 2006 | 620 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2003 | 189 | 0.050 |
Why?
|
| Apoptosis | 3 | 2019 | 1789 | 0.050 |
Why?
|
| Stem Cells | 1 | 2006 | 692 | 0.050 |
Why?
|
| Diaphragm | 1 | 2022 | 98 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 575 | 0.050 |
Why?
|
| Critical Care | 2 | 2017 | 657 | 0.050 |
Why?
|
| Length of Stay | 2 | 2017 | 1310 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2022 | 244 | 0.050 |
Why?
|
| Age of Onset | 2 | 2013 | 586 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 453 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 2 | 2011 | 124 | 0.040 |
Why?
|
| Siblings | 2 | 2012 | 197 | 0.040 |
Why?
|
| Embryonic Development | 2 | 2017 | 215 | 0.040 |
Why?
|
| Linear Models | 1 | 2002 | 671 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 2 | 2013 | 310 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 2154 | 0.040 |
Why?
|
| Aging | 1 | 2007 | 1182 | 0.040 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 543 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2015 | 806 | 0.040 |
Why?
|
| Genes, Protozoan | 3 | 2004 | 25 | 0.040 |
Why?
|
| Rats | 4 | 2007 | 3677 | 0.040 |
Why?
|
| Ataxin-7 | 2 | 2010 | 14 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2017 | 830 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2002 | 646 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2016 | 757 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 573 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 63 | 0.040 |
Why?
|
| Thanatophoric Dysplasia | 1 | 2019 | 6 | 0.040 |
Why?
|
| Lymphangioma, Cystic | 1 | 2019 | 16 | 0.040 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2019 | 18 | 0.040 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2011 | 65 | 0.040 |
Why?
|
| Time Factors | 4 | 2013 | 6292 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2019 | 47 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 2017 | 1151 | 0.040 |
Why?
|
| Achondroplasia | 1 | 2019 | 23 | 0.040 |
Why?
|
| Karyotype | 1 | 2018 | 28 | 0.040 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 122 | 0.040 |
Why?
|
| Acrocephalosyndactylia | 1 | 2019 | 22 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2011 | 58 | 0.040 |
Why?
|
| Receptor, PAR-1 | 1 | 2018 | 3 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2015 | 622 | 0.040 |
Why?
|
| Hospitalization | 2 | 2018 | 1777 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2019 | 165 | 0.040 |
Why?
|
| Hydrops Fetalis | 1 | 2019 | 75 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2019 | 112 | 0.040 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2019 | 44 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2021 | 356 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2019 | 237 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 2008 | 260 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 60 | 0.040 |
Why?
|
| Genomic Structural Variation | 1 | 2019 | 86 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2018 | 55 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 126 | 0.040 |
Why?
|
| Infant Care | 1 | 2017 | 46 | 0.040 |
Why?
|
| Veratrum Alkaloids | 1 | 2017 | 11 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 127 | 0.040 |
Why?
|
| GATA1 Transcription Factor | 1 | 2017 | 9 | 0.030 |
Why?
|
| Oxygen Consumption | 2 | 2009 | 305 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2017 | 49 | 0.030 |
Why?
|
| Antigenic Variation | 1 | 2017 | 39 | 0.030 |
Why?
|
| Chondrocytes | 2 | 2008 | 50 | 0.030 |
Why?
|
| Haemophilus | 1 | 2016 | 13 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2017 | 89 | 0.030 |
Why?
|
| Pregnancy, High-Risk | 1 | 2016 | 43 | 0.030 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2019 | 148 | 0.030 |
Why?
|
| Consanguinity | 1 | 2017 | 116 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2013 | 862 | 0.030 |
Why?
|
| Viral Fusion Proteins | 1 | 2017 | 76 | 0.030 |
Why?
|
| RNA Stability | 2 | 2008 | 84 | 0.030 |
Why?
|
| Perfusion | 2 | 2007 | 203 | 0.030 |
Why?
|
| Chromatin | 2 | 2012 | 551 | 0.030 |
Why?
|
| Workflow | 1 | 2017 | 117 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2016 | 101 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 253 | 0.030 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 1 | 2017 | 67 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 165 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 114 | 0.030 |
Why?
|
| Quinazolines | 1 | 2017 | 174 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 134 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 264 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2018 | 478 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 211 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 11 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 10 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2015 | 28 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 393 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 214 | 0.030 |
Why?
|
| Common Cold | 1 | 2015 | 24 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 62 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 49 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 2015 | 58 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 38 | 0.030 |
Why?
|
| Transcriptional Activation | 2 | 2008 | 484 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2015 | 80 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 67 | 0.030 |
Why?
|
| Ischemia | 1 | 2018 | 357 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2015 | 80 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2018 | 467 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 1062 | 0.030 |
Why?
|
| Platelet Function Tests | 1 | 2014 | 40 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2009 | 1014 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2017 | 348 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2006 | 286 | 0.030 |
Why?
|
| Introns | 1 | 2015 | 299 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 555 | 0.030 |
Why?
|
| Ribonuclease III | 1 | 2015 | 89 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2015 | 309 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 384 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 115 | 0.030 |
Why?
|
| Epinephrine | 1 | 2015 | 179 | 0.030 |
Why?
|
| Influenza A virus | 1 | 2015 | 138 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2017 | 369 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2015 | 227 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 793 | 0.030 |
Why?
|
| Embolism, Cholesterol | 1 | 2013 | 3 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 375 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2007 | 378 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 523 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2013 | 55 | 0.030 |
Why?
|
| Poland | 1 | 2013 | 47 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 315 | 0.030 |
Why?
|
| Microcephaly | 1 | 2017 | 330 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 171 | 0.030 |
Why?
|
| Ribosomes | 1 | 2014 | 137 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 221 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 85 | 0.030 |
Why?
|
| Age Factors | 2 | 2014 | 2818 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 797 | 0.030 |
Why?
|
| Neuropeptide Y | 1 | 2013 | 36 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 555 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 402 | 0.030 |
Why?
|
| Base Composition | 1 | 2013 | 71 | 0.030 |
Why?
|
| Rotavirus | 1 | 2017 | 498 | 0.030 |
Why?
|
| Parents | 1 | 2020 | 1015 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 43 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2015 | 397 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 1254 | 0.030 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2013 | 58 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 836 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2013 | 106 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 505 | 0.030 |
Why?
|
| Hypothermia | 1 | 2013 | 57 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 330 | 0.030 |
Why?
|
| Cell Division | 1 | 2014 | 777 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 162 | 0.030 |
Why?
|
| Base Pairing | 1 | 2012 | 42 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2013 | 245 | 0.030 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2012 | 29 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2015 | 428 | 0.020 |
Why?
|
| Gene Order | 1 | 2012 | 79 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2014 | 363 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 256 | 0.020 |
Why?
|
| Abnormal Karyotype | 1 | 2012 | 6 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2013 | 184 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2013 | 427 | 0.020 |
Why?
|
| Genome | 1 | 2015 | 472 | 0.020 |
Why?
|
| Cell Size | 1 | 2012 | 81 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 744 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2012 | 85 | 0.020 |
Why?
|
| Corticosterone | 1 | 2012 | 59 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 267 | 0.020 |
Why?
|
| CpG Islands | 1 | 2013 | 323 | 0.020 |
Why?
|
| Eye Abnormalities | 1 | 2012 | 104 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2014 | 331 | 0.020 |
Why?
|
| Spindle Apparatus | 1 | 2011 | 63 | 0.020 |
Why?
|
| Glucose | 2 | 2007 | 880 | 0.020 |
Why?
|
| Metabolome | 1 | 2014 | 294 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2011 | 64 | 0.020 |
Why?
|
| Sumoylation | 1 | 2011 | 35 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2011 | 17 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2012 | 144 | 0.020 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2011 | 17 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 579 | 0.020 |
Why?
|
| Models, Biological | 2 | 2008 | 1459 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 254 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 1032 | 0.020 |
Why?
|
| Environment | 1 | 2012 | 145 | 0.020 |
Why?
|
| Mitosis | 1 | 2011 | 235 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 77 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 254 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 374 | 0.020 |
Why?
|
| Receptors, Odorant | 1 | 2011 | 36 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 672 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 198 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 2012 | 150 | 0.020 |
Why?
|
| Metabolomics | 1 | 2014 | 422 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2012 | 224 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1690 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2004 | 1069 | 0.020 |
Why?
|
| Cadherins | 1 | 2011 | 166 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 247 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 256 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 460 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1280 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2012 | 406 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 498 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 298 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 12324 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 325 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 541 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2011 | 283 | 0.020 |
Why?
|
| Inverted Repeat Sequences | 1 | 2009 | 13 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2009 | 107 | 0.020 |
Why?
|
| Calorimetry, Indirect | 1 | 2009 | 56 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2009 | 97 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2009 | 26 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2012 | 198 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 357 | 0.020 |
Why?
|
| Bipolar Disorder | 1 | 2011 | 306 | 0.020 |
Why?
|
| Deoxyuracil Nucleotides | 1 | 2008 | 6 | 0.020 |
Why?
|
| Chondrogenesis | 1 | 2008 | 26 | 0.020 |
Why?
|
| United States | 2 | 2016 | 10887 | 0.020 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2008 | 34 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 125 | 0.020 |
Why?
|
| RNA, Small Untranslated | 1 | 2008 | 21 | 0.020 |
Why?
|
| Skin Pigmentation | 1 | 2008 | 27 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2009 | 208 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 2891 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2008 | 144 | 0.020 |
Why?
|
| Reference Standards | 1 | 2009 | 238 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 425 | 0.020 |
Why?
|
| Telemetry | 1 | 2007 | 27 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2007 | 8 | 0.020 |
Why?
|
| Tretinoin | 1 | 2008 | 116 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2008 | 107 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 184 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 48 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2009 | 156 | 0.020 |
Why?
|
| Failure to Thrive | 1 | 2008 | 90 | 0.020 |
Why?
|
| PAX6 Transcription Factor | 1 | 2007 | 37 | 0.020 |
Why?
|
| CLOCK Proteins | 1 | 2007 | 28 | 0.020 |
Why?
|
| Family | 1 | 2011 | 562 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2007 | 60 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2007 | 73 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 291 | 0.020 |
Why?
|
| Glycogenolysis | 1 | 2007 | 10 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2007 | 31 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2007 | 56 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 94 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2007 | 41 | 0.020 |
Why?
|
| Protein Methyltransferases | 1 | 2007 | 9 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2009 | 295 | 0.020 |
Why?
|
| Retina | 1 | 2010 | 450 | 0.020 |
Why?
|
| Allelic Imbalance | 1 | 2007 | 11 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2007 | 74 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2007 | 62 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2007 | 57 | 0.020 |
Why?
|
| Cognition | 1 | 2012 | 721 | 0.020 |
Why?
|
| Medicare | 1 | 2010 | 424 | 0.020 |
Why?
|
| P-Selectin | 1 | 2007 | 78 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 822 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2007 | 63 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2007 | 92 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2007 | 118 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2007 | 90 | 0.020 |
Why?
|
| Maze Learning | 1 | 2007 | 128 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2007 | 193 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2007 | 154 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2006 | 25 | 0.020 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2007 | 124 | 0.020 |
Why?
|
| Terminal Repeat Sequences | 1 | 2006 | 18 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2006 | 69 | 0.020 |
Why?
|
| Cyclin T | 1 | 2006 | 34 | 0.020 |
Why?
|
| Energy Intake | 1 | 2009 | 493 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 440 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2006 | 56 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2009 | 356 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2007 | 219 | 0.020 |
Why?
|
| Probability | 1 | 2006 | 320 | 0.020 |
Why?
|
| Fertilization in Vitro | 1 | 2007 | 147 | 0.020 |
Why?
|
| RNA, Ribosomal, 5.8S | 1 | 2005 | 6 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2006 | 100 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2007 | 453 | 0.020 |
Why?
|
| Drug Resistance, Multiple | 1 | 2005 | 48 | 0.020 |
Why?
|
| Uncoupling Protein 3 | 1 | 2005 | 6 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 711 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 1529 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 2005 | 70 | 0.020 |
Why?
|
| Sympathomimetics | 1 | 2005 | 12 | 0.020 |
Why?
|
| Dendrites | 1 | 2007 | 203 | 0.020 |
Why?
|
| ARNTL Transcription Factors | 1 | 2005 | 38 | 0.020 |
Why?
|
| Period Circadian Proteins | 1 | 2005 | 29 | 0.020 |
Why?
|
| Animals, Suckling | 1 | 2005 | 50 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2005 | 21 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 680 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2007 | 455 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 1237 | 0.010 |
Why?
|
| Heart Rate | 1 | 2007 | 590 | 0.010 |
Why?
|
| Myosin Type I | 1 | 2004 | 2 | 0.010 |
Why?
|
| Cellulase | 1 | 2004 | 3 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2005 | 175 | 0.010 |
Why?
|
| Body Weight | 1 | 2009 | 996 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2007 | 368 | 0.010 |
Why?
|
| Spores, Protozoan | 1 | 2004 | 18 | 0.010 |
Why?
|
| RNA, Protozoan | 1 | 2004 | 10 | 0.010 |
Why?
|
| Fasting | 1 | 2006 | 298 | 0.010 |
Why?
|
| Chromosome Inversion | 1 | 2005 | 74 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2007 | 417 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 1645 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2009 | 1138 | 0.010 |
Why?
|
| Binding Sites | 1 | 2007 | 1295 | 0.010 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2006 | 241 | 0.010 |
Why?
|
| Leukocytes | 1 | 2005 | 205 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2005 | 209 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 486 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 1738 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2009 | 637 | 0.010 |
Why?
|
| Ion Channels | 1 | 2005 | 191 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2006 | 575 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 522 | 0.010 |
Why?
|
| Memory | 1 | 2007 | 363 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5145 | 0.010 |
Why?
|
| Triglycerides | 1 | 2006 | 575 | 0.010 |
Why?
|
| Cell Fusion | 1 | 2003 | 37 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2005 | 276 | 0.010 |
Why?
|
| Chimera | 1 | 2003 | 83 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2005 | 332 | 0.010 |
Why?
|
| Research Design | 1 | 2007 | 691 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2003 | 246 | 0.010 |
Why?
|
| Inflammation | 1 | 2010 | 1431 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 723 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 413 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2003 | 221 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 201 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2003 | 211 | 0.010 |
Why?
|
| Echocardiography | 1 | 2007 | 1052 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2007 | 971 | 0.010 |
Why?
|
| Genome, Protozoan | 1 | 2002 | 25 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 376 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 797 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 1328 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 3553 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2006 | 1177 | 0.010 |
Why?
|
| Decision Making | 1 | 2006 | 655 | 0.010 |
Why?
|
| Hippocampus | 1 | 2007 | 821 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 570 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 767 | 0.010 |
Why?
|
| Cytokines | 1 | 2005 | 1291 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 1390 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 3424 | 0.010 |
Why?
|